CoChat

Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical Trial

Open access
Sherr, Jennifer L., Bode, Bruce W., Forlenza, Gregory P., Laffel, Lori M., Schoelwer, Melissa J., Buckingham, Bruce A., Criego, Amy B., DeSalvo, Daniel J., MacLeish, Sarah A., Hansen, David W., Ly, Trang T., for the Omnipod 5 in Preschoolers Study Group:, Sherr, Jennifer L., Weyman, Kate, Tichy, Eileen, VanName, Michelle, Brei, Michelle, Zgorski, Melinda, Steffen, Amy, Carria, Lori, Bode, Bruce W., Busby, Anna, Forlenza, Gregory P., Wadwa, R. Paul, Slover, Robert, Cobry, Erin, Messer, Laurel, Laffel, Lori M., Isganaitis, Elvira, Ambler-Osborn, Louise, Freiner, Emily, Turcotte, Christine, Volkening, Lisa, Schoelwer, Melissa, Brown, Sue A., Krauthause, Katie, Emory, Emma, Oliveri, Mary, Buckingham, Bruce A., Ekhlaspour, Laya, Kingman, Ryan, Criego, Amy B., Schwartz, Betsy L., Gandrud, Laura M., Grieme, Aimee, Hyatt, Jamie, DeSalvo, Daniel J., McKay, Siripoom, DeLaO, Kylie, Villegas, Carolina, MacLeish, Sarah A., Wood, Jamie R., Kaminski, Beth A., Casey, Terri, Campbell, Wendy, Behm, Kim, Adams, Ramon, Hansen, David W., Stone, Sheri L., Bzdick, Suzan, Bulger, Jane, Agostini, Lynn, Doolittle, Sarah, Kivilaid, Kaisa, Kleve, Krista, Ly, Trang T., Dumais, Bonnie, Vienneau, Todd, Huyett, Lauren M., Lee, Joon Bok, O’Connor, Jason, Benjamin, Eric · 2022 · Diabetes Care
Cited by 97

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Very young children with type 1 diabetes often struggle to achieve glycemic targets, putting them at risk for long-term complications and creating an immense management burden for caregivers. We conducted the first evaluation of the Omnipod 5 Automated Insulin Delivery System in this population. RESEARCH DESIGN AND METHODS: A total of 80 children aged 2.0–5.9 years used the investigational system in a single-arm study for 13 weeks following 14 days of baseline data collection with their usual therapy. RESULTS: There were no episodes of severe hypoglycemia or diabetic ketoacidosis. By study end, HbA1c decreased by 0.55% (6.0 mmol/mol) (P < 0.0001). Time with sensor glucose levels in target range 70–180 mg/dL increased by 10.9%, or 2.6 h/day (P < 0.0001), while time with levels <70 mg/dL declined by median 0.27% (P = 0.0204). CONCLUSIONS: Use of the automated insulin delivery system was safe, and participants experienced improved glycemic measures and reduced hypoglycemia during the study phase compared with baseline.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc21-2359

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 97

Metadata

Authors
Sherr, J. L., Bode, B. W., Forlenza, G. P., Laffel, L. M., Schoelwer, M. J., Buckingham, B. A., Criego, A. B., DeSalvo, D. J., MacLeish, S. A., Hansen, D. W., Ly, T. T., for the Omnipod 5 in Preschoolers Study Group:, Sherr, J. L., Weyman, K., Tichy, E., VanName, M., Brei, M., Zgorski, M., Steffen, A., Carria, L., Bode, B. W., Busby, A., Forlenza, G. P., Wadwa, R. P., Slover, R., Cobry, E., Messer, L., Laffel, L. M., Isganaitis, E., Ambler-Osborn, L., Freiner, E., Turcotte, C., Volkening, L., Schoelwer, M., Brown, S. A., Krauthause, K., Emory, E., Oliveri, M., Buckingham, B. A., Ekhlaspour, L., Kingman, R., Criego, A. B., Schwartz, B. L., Gandrud, L. M., Grieme, A., Hyatt, J., DeSalvo, D. J., McKay, S., DeLaO, K., Villegas, C., MacLeish, S. A., Wood, J. R., Kaminski, B. A., Casey, T., Campbell, W., Behm, K., Adams, R., Hansen, D. W., Stone, S. L., Bzdick, S., Bulger, J., Agostini, L., Doolittle, S., Kivilaid, K., Kleve, K., Ly, T. T., Dumais, B., Vienneau, T., Huyett, L. M., Lee, J. B., O’Connor, J., & Benjamin, E.
Venue
Diabetes Care
Published
2022-07-26
Volume
45
Issue
8
Pages
1907-1910
ISSN
0149-5992 (ISSN-L)
OpenAlex
W4281713367
Cited by
97
References
8
FWCI
11.29
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.